Phase I data for novel lentiviral vector therapy for children with Fanconi anemia Feb. 28, 2020 No Comments
Bluebird bio presents phase I/II data on LentiGlobin for sickle cell disease Feb. 25, 2020 No Comments
AMT-060 gene therapy provides long-term factor IX activity in hemophilia B patients Feb. 10, 2020 No Comments
First-in-human data show safety and early hemostatic efficacy of BAY-2599023 Feb. 10, 2020 No Comments
RSS